David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics gives an overview of his abstract, Rb1 suppresses prostate cancer metastasis and lineage plasticity underlying castration resistance, which was presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Abstract Overview: Resistance to Anti-Androgen Therapy in Patients with Prostate Cancer
